Robert A. Schwartzman

Array ( [id] => 3804104 [patent_doc_number] => 05830759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Unique associated Kaposi\'s sarcoma virus sequences and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/343101 [patent_app_country] => US [patent_app_date] => 1994-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 28911 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830759.pdf [firstpage_image] =>[orig_patent_app_number] => 343101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3685583 [patent_doc_number] => 05643726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Methods for modulating transcription from the amyloid .beta.-protein precursor (APP) promoter' [patent_app_type] => 1 [patent_app_number] => 8/339152 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 41 [patent_no_of_words] => 21433 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643726.pdf [firstpage_image] =>[orig_patent_app_number] => 339152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784528 [patent_doc_number] => 05840521 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Expression vector containing an inducible selection gene system' [patent_app_type] => 1 [patent_app_number] => 8/338793 [patent_app_country] => US [patent_app_date] => 1994-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 27 [patent_no_of_words] => 22270 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840521.pdf [firstpage_image] =>[orig_patent_app_number] => 338793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857865 [patent_doc_number] => 05792632 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Nucleotide sequence encoding the enzyme I-SceI and the uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/336241 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 64 [patent_no_of_words] => 24126 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792632.pdf [firstpage_image] =>[orig_patent_app_number] => 336241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4028528 [patent_doc_number] => 05994127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'In vivo production and delivery of erythropoietin or insulinotropin for gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/334455 [patent_app_country] => US [patent_app_date] => 1994-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 13471 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994127.pdf [firstpage_image] =>[orig_patent_app_number] => 334455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3681292 [patent_doc_number] => 05633154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Method for location of insertion elements' [patent_app_type] => 1 [patent_app_number] => 8/336069 [patent_app_country] => US [patent_app_date] => 1994-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6691 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633154.pdf [firstpage_image] =>[orig_patent_app_number] => 336069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660549 [patent_doc_number] => 05624827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'DNA sequences encoding the plant toxin gelonin' [patent_app_type] => 1 [patent_app_number] => 8/327440 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5120 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624827.pdf [firstpage_image] =>[orig_patent_app_number] => 327440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756924 [patent_doc_number] => 05843646 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'DNA molecules encoding murine son of sevenless (mSOS) gene and mSOS polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/290731 [patent_app_country] => US [patent_app_date] => 1994-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 64 [patent_no_of_words] => 4862 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843646.pdf [firstpage_image] =>[orig_patent_app_number] => 290731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045417 [patent_doc_number] => 05869304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Technique for specifying the fatty acid at the sn2 position of acylglycerol lipids' [patent_app_type] => 1 [patent_app_number] => 8/321670 [patent_app_country] => US [patent_app_date] => 1994-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 19 [patent_no_of_words] => 10364 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869304.pdf [firstpage_image] =>[orig_patent_app_number] => 321670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636296 [patent_doc_number] => 05631359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Hairpin ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/321993 [patent_app_country] => US [patent_app_date] => 1994-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 5432 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631359.pdf [firstpage_image] =>[orig_patent_app_number] => 321993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722995 [patent_doc_number] => 05681735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Transcription control element for increasing gene expression in myoblasts' [patent_app_type] => 1 [patent_app_number] => 8/313181 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 10050 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681735.pdf [firstpage_image] =>[orig_patent_app_number] => 313181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936362 [patent_doc_number] => 05929223 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Cloning and characterizing of genes associated with long-term memory' [patent_app_type] => 1 [patent_app_number] => 8/319866 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 28 [patent_no_of_words] => 32674 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929223.pdf [firstpage_image] =>[orig_patent_app_number] => 319866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154532 [patent_doc_number] => 06114167 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Ribozymes targeting the MoMLV PSI packaging sequence and the HIV tat sequence' [patent_app_type] => 1 [patent_app_number] => 8/310259 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 30 [patent_no_of_words] => 17230 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114167.pdf [firstpage_image] =>[orig_patent_app_number] => 310259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759625 [patent_doc_number] => 05741679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Regulatable nucleic acid therapeutic and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/307401 [patent_app_country] => US [patent_app_date] => 1994-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 5415 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741679.pdf [firstpage_image] =>[orig_patent_app_number] => 307401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772151 [patent_doc_number] => 05734039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Antisense oligonucleotides targeting cooperating oncogenes' [patent_app_type] => 1 [patent_app_number] => 8/306691 [patent_app_country] => US [patent_app_date] => 1994-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 22611 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/734/05734039.pdf [firstpage_image] =>[orig_patent_app_number] => 306691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3830595 [patent_doc_number] => 05712093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'RXR homodimer formation' [patent_app_type] => 1 [patent_app_number] => 8/297706 [patent_app_country] => US [patent_app_date] => 1994-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 15 [patent_no_of_words] => 7403 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712093.pdf [firstpage_image] =>[orig_patent_app_number] => 297706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245134 [patent_doc_number] => 06136605 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Glutathione S-transferase isoforms' [patent_app_type] => 1 [patent_app_number] => 8/297431 [patent_app_country] => US [patent_app_date] => 1994-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20614 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136605.pdf [firstpage_image] =>[orig_patent_app_number] => 297431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3887882 [patent_doc_number] => 05834266 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Regulated apoptosis' [patent_app_type] => 1 [patent_app_number] => 8/292597 [patent_app_country] => US [patent_app_date] => 1994-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 35 [patent_no_of_words] => 40676 [patent_no_of_claims] => 235 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834266.pdf [firstpage_image] =>[orig_patent_app_number] => 292597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694137 [patent_doc_number] => 05661033 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Gene transfer using herpes virus vectors as a tool for neuroprotection' [patent_app_type] => 1 [patent_app_number] => 8/287042 [patent_app_country] => US [patent_app_date] => 1994-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 16143 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661033.pdf [firstpage_image] =>[orig_patent_app_number] => 287042 [rel_patent_id] =>[rel_patent_doc_number] =>)